Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tgf tgf bcr abl'

Search results for: 'research area tgf tgf bcr abl'

Items 41-50 of 82

Page
per page
  1. Rocuronium Bromide
    A1366 Rocuronium Bromide
    Summary: TGF-βR I kinase inhibitor
      ≥30.48 mg/mL
  2. NSI-189
    B1150 NSI-189
    Summary: Nootropic and neurogenic research chemical
      Soluble in DMSO
  3. IDE 1
    B7566 IDE 1
    Summary: activate the TGF-β signaling pathway
      insoluble in H2O; ≥59.7 mg/mL
  4. KW 2449
    A4123 KW 2449
    Target: Aurora Kinases|FLT3|Bcr-Abl
    Summary: Multikinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.6 mg/mL
  5. Tamoxifen
    B5965 Tamoxifen
     1 Citation
    Target: PKC
    Summary: TGF-β modulatory and PKC inhibitory effects
      ≥18.6 mg/mL
  6. Dasatinib hydrochloride
    A3351 Dasatinib hydrochloride
    Summary: Multi-BCR/Abl and Src kinase inhibitor, oral active
      insoluble in EtOH; insoluble in H2O; ≥8.41 mg/mL
  7. AG957
    C5826 AG957
    Summary: a tyrphostin that targets transforming Bcr-Abl fusion proteins
  8. LY364947
    B2287 LY364947
     1 Citation
    Summary: inhibitor of TGF-β type I receptor kinase domain
      insoluble in EtOH; insoluble in H2O; ≥24.4 mg/mL
  9. EW-7197
    B5946 EW-7197
     1 Citation
    Target: BMP and Other Activin Receptors
    Summary: Selective inhibitor of TGF-β type I receptor kinase
      ≥39.9 mg/mL
  10. XL228
    A3939 XL228
    Summary: IGF1R/AURORA /FGFR1-3/ABL/SRC family kinases inhibitor
      ≥21.9 mg/mL

Items 41-50 of 82

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options